Cargando…
Target Identification in Anti-Tuberculosis Drug Discovery
Mycobacterium tuberculosis (Mtb) is the etiological agent of tuberculosis (TB), a disease that, although preventable and curable, remains a global epidemic due to the emergence of resistance and a latent form responsible for a long period of treatment. Drug discovery in TB is a challenging task due...
Autores principales: | Capela, Rita, Félix, Rita, Clariano, Marta, Nunes, Diogo, Perry, Maria de Jesus, Lopes, Francisca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341898/ https://www.ncbi.nlm.nih.gov/pubmed/37445660 http://dx.doi.org/10.3390/ijms241310482 |
Ejemplares similares
-
An Overview of Drug Resistance in Protozoal Diseases
por: Capela, Rita, et al.
Publicado: (2019) -
Insights into Integrated Lead Generation and Target
Identification in Malaria and Tuberculosis Drug Discovery
por: Okombo, John, et al.
Publicado: (2017) -
Current Screening Methodologies in Drug Discovery for Selected Human Diseases
por: Lage, Olga Maria, et al.
Publicado: (2018) -
Mycobacterium tuberculosis Shikimate Pathway Enzymes as Targets for the Rational Design of Anti-Tuberculosis Drugs
por: Nunes, José E. S., et al.
Publicado: (2020) -
Computational approaches in target identification and drug discovery
por: Katsila, Theodora, et al.
Publicado: (2016)